InvestorsHub Logo
Followers 10
Posts 529
Boards Moderated 0
Alias Born 12/15/2011

Re: ronrooster post# 38203

Thursday, 09/07/2017 11:21:05 AM

Thursday, September 07, 2017 11:21:05 AM

Post# of 38376
This is going to get very interesting...They keep hitting homes runs with their NR2F6 drug development program with ChemDiv(medicinal chem) and identifying small molecule drugs that can be used for cancer and drugs for autoimmune diseases. Novel compounds in fact!! All of the work at RGBP translates to the veterinary business here at ENTB..Big bucks get paid for this by the large pharma companies...Which management has stated themselves. The current valuation does not reflect the key milestone developments and progress. In addition, they have created a team at ENTB(Zander) with lots of broad veterinary expertise and talent to move the NR2F6 drug development into the veterinary field. All IMO. GL.




Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.